(Q37529775)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19552489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Current treatment of pseudomonal infections in the elderly (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19552489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19552489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

3

Matthew E Falagas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19552489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Kaiti Saplaoura

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19552489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19552489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19552489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19552489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19552489%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

363-379

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19552489%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002512-200926050-00001

1 February 2020

exact match

0 references

cites work

Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. Implications for infection control

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200926050-00001

Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200926050-00001

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200926050-00001

In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200926050-00001

Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200926050-00001

In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200926050-00001

Single or multiple daily doses of aminoglycosides: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200926050-00001

Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study

21 January 2018

1 reference

12 December 2020

Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.

1 reference

12 December 2020

Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance

1 reference

12 December 2020

Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature

1 reference

12 December 2020

Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem

1 reference

12 December 2020

Immunomodulatory intervention in sepsis by multidrug-resistant Pseudomonas aeruginosa with thalidomide: an experimental study.

1 reference

12 December 2020

Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa

1 reference

12 December 2020

Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis

1 reference

12 December 2020

Predictors of mortality in nursing home residents

1 reference

12 December 2020

Factors Predisposing to Oropharyngeal Colonization with Gram-Negative Bacilli in the Aged

1 reference

12 December 2020

Global patterns of healthy life expectancy in the year 2002

1 reference

12 December 2020

Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature

1 reference

12 December 2020

Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model

1 reference

12 December 2020

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents

1 reference

12 December 2020

Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes

1 reference

12 December 2020

Risk factors for toxicity in elderly patients given aminoglycosides once daily.

1 reference

12 December 2020

Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world

1 reference

12 December 2020

Pseudomonas aeruginosa in chronic obstructive pulmonary disease.

1 reference

12 December 2020

Contribution of tap water to patient colonisation with Pseudomonas aeruginosa in a medical intensive care unit

1 reference

12 December 2020

Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides

1 reference

12 December 2020

Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

1 reference

12 December 2020

Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.

1 reference

12 December 2020

Analysis of transmission pathways of Pseudomonas aeruginosa between patients and tap water outlets

1 reference

12 December 2020

Colonization of dental plaques: a reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders.

1 reference

12 December 2020

Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria.

1 reference

12 December 2020

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

1 reference

12 December 2020

Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.

1 reference

12 December 2020

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

1 reference

12 December 2020

Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients

1 reference

12 December 2020

Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B.

1 reference

12 December 2020

Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis

1 reference

12 December 2020

Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies

1 reference

12 December 2020

Pseudomonas aeruginosa: resistance and therapy

1 reference

12 December 2020

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

1 reference

12 December 2020

Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study

1 reference

12 December 2020

Asymptomatic bacteriuria among the institutionalized elderly.

1 reference

12 December 2020

Prescribing for older people

1 reference

12 December 2020

Trends in healthy life expectancy in the United States, 1970-1990: gender, racial, and educational differences

1 reference

12 December 2020

Of Pseudomonas, porins, pumps and carbapenems.

1 reference

12 December 2020

Health, life expectancy, and health care spending among the elderly.

1 reference

12 December 2020

Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase

1 reference

12 December 2020

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

12 December 2020

Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience

1 reference

12 December 2020

Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia

1 reference

12 December 2020

Aminoglycoside-associated nephrotoxicity in the elderly

1 reference

12 December 2020

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment

1 reference

12 December 2020

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

1 reference

12 December 2020

Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations

1 reference

12 December 2020

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

1 reference

12 December 2020

Professional oral health care by dental hygienists reduced respiratory infections in elderly persons requiring nursing care

1 reference

12 December 2020

Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates

1 reference

12 December 2020

Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa

1 reference

12 December 2020

Microbiologic survey of long-term care facilities

1 reference

12 December 2020

An outbreak of Pseudomonas aeruginosa infection caused by contaminated mouth swabs

1 reference

12 December 2020

Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy

1 reference

12 December 2020

Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.

1 reference

12 December 2020

Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity

1 reference

12 December 2020

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

1 reference

12 December 2020

Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa

1 reference

12 December 2020

Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes

1 reference

12 December 2020

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis

1 reference

12 December 2020

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

1 reference

12 December 2020

Spread of integron-associated VIM-type metallo-beta-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals

1 reference

12 December 2020

Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection.

1 reference

12 December 2020

Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin.

1 reference

12 December 2020

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

1 reference

12 December 2020

Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia

1 reference

12 December 2020

Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients

1 reference

12 December 2020

Risk factors for isolation of strains susceptible only to polymyxin among patients with Pseudomonas aeruginosa bacteremia

1 reference

12 December 2020

Infections and antibiotic resistance in nursing homes

1 reference

12 December 2020

Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies.

1 reference

12 December 2020

Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia.

1 reference

12 December 2020

Emerging carbapenemases in Gram-negative aerobes

1 reference

12 December 2020

Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators

1 reference

12 December 2020

Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.

1 reference

12 December 2020

Pseudomonas aeruginosa bloodstream infections: how should we treat them?

1 reference

12 December 2020

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience

1 reference

12 December 2020

Where do the elderly die? The impact of nursing home utilisation on the place of death. Observations from a mortality cohort study in Flanders.

1 reference

12 December 2020

Neurotoxicity of carbapenem antibacterials

1 reference

12 December 2020

Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations

1 reference

12 December 2020

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

1 reference

12 December 2020

Central role of quorum sensing in regulating the production of pathogenicity factors in Pseudomonas aeruginosa.

1 reference

12 December 2020

Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes

1 reference

12 December 2020

Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology.

1 reference

12 December 2020

Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa

1 reference

12 December 2020

High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.

1 reference

12 December 2020

Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients

1 reference

12 December 2020

Addressing resistance evolution in Pseudomonas aeruginosa using pharmacodynamic modelling: application to meropenem dosage and combination therapy

1 reference

12 December 2020

Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.

1 reference

12 December 2020

Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro

1 reference

12 December 2020

Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa

1 reference

12 December 2020

Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa

1 reference

12 December 2020

The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species

1 reference

12 December 2020

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

1 reference

12 December 2020

Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential

1 reference

12 December 2020

The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains

1 reference

12 December 2020

Etiologic study of patients with community-acquired pneumonia

1 reference

12 December 2020

A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission?

1 reference

12 December 2020

Antimicrobial resistance of Pseudomonas aeruginosa biofilms

1 reference

12 December 2020

Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa

1 reference

12 December 2020

Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint

1 reference

12 December 2020

Bacterial infection in exacerbated COPD with changes in sputum characteristics

1 reference

12 December 2020

The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections

1 reference

12 December 2020

Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital

1 reference

12 December 2020

Nephrotoxicity of intravenous colistin: a prospective evaluation

1 reference

12 December 2020

Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.

1 reference

12 December 2020

The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa

1 reference

12 December 2020

Prognostic Factors of Pneumonia Requiring Admission to the Intensive Care Unit

1 reference

12 December 2020

Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).

1 reference

12 December 2020

Prolonged outbreak of infection due to TEM-21-producing strains of Pseudomonas aeruginosa and enterobacteria in a nursing home

1 reference

12 December 2020

Current therapies for pseudomonas aeruginosa.

1 reference

12 December 2020

Pathogenic colonization of the stomach in enterally fed elderly patients: Comparing percutaneous endoscopic gastrostomy with nasogastric tube.

1 reference

12 December 2020

Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study

1 reference

12 December 2020

Cell-to-cell signaling and Pseudomonas aeruginosa infections

1 reference

12 December 2020